BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2663025)

  • 1. Immunopathology of liver transplantation.
    Demetris AJ; Markus BH
    Crit Rev Immunol; 1989; 9(2):67-92. PubMed ID: 2663025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunology of experimental liver transplantation in the rat.
    Kamada N
    Immunology; 1985 Jul; 55(3):369-89. PubMed ID: 3894220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique aspects of rejection and tolerance in liver transplantation.
    Knechtle SJ; Kwun J
    Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting liver transplant immunology: from the concept of immune engagement to the dualistic pathway paradigm.
    Reding R; Davies HF
    Liver Transpl; 2004 Sep; 10(9):1081-6. PubMed ID: 15349996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
    Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
    Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orthotopic liver transplantation in the rat].
    Tsuchimoto S
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):776-99. PubMed ID: 2946635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody deposition in liver allografts with chronic rejection.
    Demetris AJ; Markus BH; Burnham J; Nalesnik M; Gordon RD; Makowka L; Starzl TE
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):121-5. PubMed ID: 3303563
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver retransplantation: indications and outcomes.
    Wang ZF; Liu C
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):175-8. PubMed ID: 15138104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunology of liver transplantation: clinical management aspects.
    Shah V; Friedman AL; Navarro VJ
    Gastroenterologist; 1997 Jun; 5(2):137-47. PubMed ID: 9193931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver transplantation in swine: a model for tolerance induction].
    Lenti LM; Rademacher J; Cansolino L; Crespi S; Oldani G; Novelli G; Agoglitta D; Tubazio I; Misitano P; Gaspari A; Maestri M; Dionigi P
    Minerva Chir; 2006 Oct; 61(5):393-402. PubMed ID: 17159747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation.
    Sanchez EQ; Levy MF; Goldstein RM; Fasola CG; Tillery GW; Netto GJ; Watkins DL; Weinstein JS; Murray NG; Byers D; Christensen LL; Klintmalm GB
    Transplantation; 2003 Dec; 76(11):1583-8. PubMed ID: 14702528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing perspectives on liver transplantation in 1988.
    Gordon RD; Starzl TE
    Clin Transpl; 1988; ():5-27. PubMed ID: 3154494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.